Share

    


In This Section

CLL Advisory Committees

ACCC would like to acknowledge our committee members for CLL projects.

Multidisciplinary CLL Care Advisory Committee

Jacqueline Barrientos
Jacqueline Barrientos, MD, MS
Chief of Hematologic Malignancies, Director of Oncological Research, Adjunct Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Mount Sinai Medical Center Comprehensive Cancer Center
Miami Beach, FL

Dr. Barrientos received her medical degree from the Ponce School of Medicine, where she was the recipient of two Howard Hughes Medical Institute Fellowship Awards for her research. She completed her internship and residency in internal medicine at the Yale-New Haven Hospital of the Yale School of Medicine, and her fellowship in Hematology/Oncology at NY Presbyterian Hospital/Weill Cornell Medical College in New York City, where she also served as chief fellow. She earned a master’s degree in clinical investigation at the Weill Cornell Graduate School of Medical Sciences.

Dr. Barrientos is board certified in hematology and medical oncology and is the principal investigator on several clinical trials involving targeted agents. Her work in several pivotal trials led to the approval of several novel therapeutic agents for the management of CLL and lymphoma. Dr. Barrientos has extensively published her research in several medical journals, and she has been honored with several awards, including the American Society of Hematology Harold Amos Medical Faculty Development Program Award.

Integrating Oral Oncolytics into Chronic Lymphocytic Leukemia Practice Advisory Committee

Jacqueline Barrientos
Jacqueline Barrientos, MD, MS
Chief of Hematologic Malignancies, Director of Oncological Research, Adjunct Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Mount Sinai Medical Center Comprehensive Cancer Center
Miami Beach, FL

Dr. Barrientos received her medical degree from the Ponce School of Medicine, where she was the recipient of two Howard Hughes Medical Institute Fellowship Awards for her research. She completed her internship and residency in internal medicine at the Yale-New Haven Hospital of the Yale School of Medicine, and her fellowship in Hematology/Oncology at NY Presbyterian Hospital/Weill Cornell Medical College in New York City, where she also served as chief fellow. She earned a master’s degree in clinical investigation at the Weill Cornell Graduate School of Medical Sciences.

Dr. Barrientos is board certified in hematology and medical oncology and is the principal investigator on several clinical trials involving targeted agents. Her work in several pivotal trials led to the approval of several novel therapeutic agents for the management of CLL and lymphoma. Dr. Barrientos has extensively published her research in several medical journals, and she has been honored with several awards, including the American Society of Hematology Harold Amos Medical Faculty Development Program Award.

A Regional Approach to Advancing Care for Chronic Lymphocytic Leukemia Patients

Jacqueline Barrientos
Jacqueline Barrientos, MD, MS
Chief of Hematologic Malignancies, Director of Oncological Research, Adjunct Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Mount Sinai Medical Center Comprehensive Cancer Center
Miami Beach, FL

Dr. Barrientos received her medical degree from the Ponce School of Medicine, where she was the recipient of two Howard Hughes Medical Institute Fellowship Awards for her research. She completed her internship and residency in internal medicine at the Yale-New Haven Hospital of the Yale School of Medicine, and her fellowship in Hematology/Oncology at NY Presbyterian Hospital/Weill Cornell Medical College in New York City, where she also served as chief fellow. She earned a master’s degree in clinical investigation at the Weill Cornell Graduate School of Medical Sciences.

Dr. Barrientos is board certified in hematology and medical oncology and is the principal investigator on several clinical trials involving targeted agents. Her work in several pivotal trials led to the approval of several novel therapeutic agents for the management of CLL and lymphoma. Dr. Barrientos has extensively published her research in several medical journals, and she has been honored with several awards, including the American Society of Hematology Harold Amos Medical Faculty Development Program Award.

Returning to Practice in the Post-COVID-19 Era: Resources for Treating Chronic Lymphocytic Leukemia

Jacqueline Barrientos
Jacqueline Barrientos, MD, MS
Chief of Hematologic Malignancies, Director of Oncological Research, Adjunct Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Mount Sinai Medical Center Comprehensive Cancer Center
Miami Beach, FL

Dr. Barrientos received her medical degree from the Ponce School of Medicine, where she was the recipient of two Howard Hughes Medical Institute Fellowship Awards for her research. She completed her internship and residency in internal medicine at the Yale-New Haven Hospital of the Yale School of Medicine, and her fellowship in Hematology/Oncology at NY Presbyterian Hospital/Weill Cornell Medical College in New York City, where she also served as chief fellow. She earned a master’s degree in clinical investigation at the Weill Cornell Graduate School of Medical Sciences.

Dr. Barrientos is board certified in hematology and medical oncology and is the principal investigator on several clinical trials involving targeted agents. Her work in several pivotal trials led to the approval of several novel therapeutic agents for the management of CLL and lymphoma. Dr. Barrientos has extensively published her research in several medical journals, and she has been honored with several awards, including the American Society of Hematology Harold Amos Medical Faculty Development Program Award.